Navigation Links
Predicting antibiotic resistance among goals of UH research
Date:12/17/2013

HOUSTON, Dec. 17, 2013 Going back in time to compare evolutionary changes in several thousand generations of E. coli, a University of Houston (UH) biologist hopes to one day be able to isolate a bacterial pathogen and predict the likelihood it will become resistant to a particular antibiotic.

A five-year, $967,431 National Science Foundation CAREER Award is allowing associate professor Timothy Cooper and his team to study the causes and consequences of evolvability in bacterial populations. Better understanding the genetic and physiological bases of evolvability is important in vaccine and antibiotic design, as well as in biotechnology. The ultimate goal is to counter it in the former, while exploiting it in the latter.

"Evolvability is when biological populations have the capacity to adapt to changing conditions," Cooper said. "By studying how generations of bacteria evolve over time, we are learning ways to predict the outcome of the changes and to understand what drives the differences in the way strains of bacteria evolve. We hope this type of evolutionary biology research will impact medical care by contributing to the ability to predict the evolutionary paths of bacterial populations."

Evolvability plays a crucial role in determining evolutionary winners and losers among the many variants that arise in any bacterial population in that they are either improved or become extinct. Through his research, Cooper wants to gain the ability to predict these winners and losers, because this knowledge gives an element of predictability to evolution. This would predict such things as antibiotic resistance.

Cooper's evolvability research with the E. coli began two years ago with the first petri dish of this fast-growing bacteria. He says they are lucky, because the experiments are incredibly simple. His team grew the initial bacteria in a petri dish and took a sample to grow in a test tube with fresh media. That process continued day after day with the bacterial populations growing and a sample being taken from each test tube culture. Cooper now has a set of experimental populations that have evolved for more than 7,000 generations.

"This simplicity is deliberate, so that we can track back what has happened to the strain," Cooper said. "Every 500 generations, which is about every two months, we freeze a sample of each evolving population to create a living fossil record. Because the frozen samples are revivable, we can compare a past population with its future population."

The comparative analysis of these past and future populations involves genome sequencing. It allows Cooper's research team, which will include a UH postdoctoral fellow, two graduate students and an undergraduate student, to determine the underlying genetic changes that have occurred, as well as to look at the effect of those changes.

"At this point, we predict an average of about 15 genetic changes to have occurred in each population evolved for the 7,000 generations," Cooper said. "Though that number may seem small, it's sufficient enough to increase the bacteria's growth rate by up to 50 percent."

Cooper became interested in studying evolvability because it is a long-standing question in evolutionary biology as something that can be modeled in most natural populations, but not measured. While it's clear from computational models that evolvability can have a major impact on how evolution unfolds, direct study of the phenomenon is required to assess just how big an impact it does have. His group's experimental system with fast-evolving bacterial populations allows them to design experiments that can look at it directly.


'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Related biology news :

1. Disease-carrying colonizers on the move: Predicting the spread of ticks across Canada
2. Researchers identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients
3. Discovery of mechanisms predicting response to new treatments in colon cancer
4. Predicting how patients respond to therapy
5. New model could help fill data gap in predicting historical air pollution exposure
6. Cellular landscaping: Predicting how, and how fast, cells will change
7. Predicting the age at menopause of women having suffered from childhood cancers
8. Predicting a low carbon future for Toronto
9. Predicting the next eye pathogen; analysis of a novel adenovirus
10. Understanding the past and predicting the future by looking across space and time
11. Predicting the life expectancy of solar modules
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Predicting antibiotic resistance among goals of UH research
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... SAN FRANCISCO , June 22, 2016  Amgen ... platinum sponsorship of the QB3@953 life sciences ... improve human health. The shared laboratory space at QB3@953 ... startups overcome a key obstacle for many early stage ... As part of the sponsorship, Amgen launched two "Amgen ...
Breaking Biology Technology: